StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeApr 8, 2026, 04:17 PM

TuHURA Biosciences Approves 2025 Performance Bonuses of $490,536 for CEO Bianco and $163,393 for CFO Dearborn, Alongside 5% Salary Increases

AI Summary

TuHURA Biosciences' Compensation Committee approved significant performance bonuses for its top executives for 2025, recognizing their contributions. Dr. James Bianco, President and CEO, received a bonus of $490,536, while CFO Dan Dearborn was awarded $163,393. Additionally, both executives received a 5% cost-of-living increase to their annual base salaries, reflecting ongoing adjustments to compensation. The filing also noted the context of updated pro forma financial statements related to the previously completed acquisition of Kineta, Inc. on June 30, 2025, which was initially announced via a merger agreement in December 2024.

Key Highlights

  • Dr. James Bianco, President and CEO, was approved for a 2025 annual performance bonus of $490,536.
  • Dan Dearborn, Chief Financial Officer, was approved for a 2025 annual performance bonus of $163,393.
  • Both Dr. Bianco and Mr. Dearborn received a 5% cost-of-living increase to their annual base salaries.
  • Dr. Bianco's new annual base salary is $605,956.
  • Mr. Dearborn's new annual base salary is $403,676.
  • The company completed its acquisition of Kineta, Inc. on June 30, 2025, as previously disclosed.